International Journal of Pediatric Otorhinolaryngology Extra
Volume 1, Issue 4 , Pages 279-281 , December 2006

Retropharyngeal abscess after BCG vaccination

  • Nima Parvaneh

      Affiliations

    • Department of Pediatrics, Infectious Disease Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Setareh Mamishi

      Affiliations

    • Department of Pediatrics, Infectious Disease Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
    • Corresponding Author InformationCorresponding author at: No. 62 Gharib Street, Tehran, Iran. Tel.: +98 21 66 92 09 82; fax: +98 21 66 92 30 54.
    • ,
  • Maryam Monajemzadeh

      Affiliations

    • Department of Pathology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Received 19 June 2006 ,Accepted 31 July 2006.

References 

  1. Coulthard M, Isaacs D. Retropharyngeal abscess. Arch. Dis. Child. 1991;66:1227–1230
  2. Philpott CM, Selvadurai D, Banerjee AR. Paediatric retropharyngeal abscess. J. Laryngol. Otol. 2004;118:919–926
  3. Casanova JL, Blanche S, Emile JF, et al. Idiopathic disseminated Bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics. 1996;98:774–778
  4. Grange JM. Complications of Bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun. Dis. Public Health. 1998;1:84–88
  5. Kostic-Joksic SA. Retropharyngeal abscess as unusual sequel of BCG vaccination. Tuberkuloza. 1953;5:61–62
  6. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29–35
  7. Lotte A, Wasz-Hockert O, Poisson N, et al. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 1984;21:107–193
  8. Casanova JL, Jouanguy E, Lamhamedi S, et al. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346:581
  9. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 2002;20:581–620
  10. Hesseling AC, Schaaf HS, Victor T, et al. Resistant Mycobacterium bovis Bacillus Calmette-Guerin disease: implications for management of Bacillus Calmette-Guerin Disease in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 2004;23:476–479
  11. Haverkamp MH, van Dissel JT, Holland SM. Human host genetic factors in non-tuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect. 2006;8:1157–1166

PII: S1871-4048(06)00079-7

doi: 10.1016/j.pedex.2006.07.008

International Journal of Pediatric Otorhinolaryngology Extra
Volume 1, Issue 4 , Pages 279-281 , December 2006

Article Tools

* Image Usage & Resolution